PRENATAL COCAINE AND DOPAMINE RECEPTOR SIGNALING
产前可卡因和多巴胺受体信号传导
基本信息
- 批准号:6175490
- 负责人:
- 金额:$ 23.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-15 至 2002-03-31
- 项目状态:已结题
- 来源:
- 关键词:G protein cocaine developmental neurobiology dopamine receptor drug abuse embryo /fetus cell /tissue embryo /fetus drug adverse effect fatty acylation immunoprecipitation ion exchange chromatography laboratory rabbit neuropharmacology palmitates phosphatidylinositols placental transfer posttranslational modifications pregnancy receptor coupling receptor sensitivity
项目摘要
Cocaine crosses the placenta and induces neurobehavioral abnormalities
in offsprings of mothers ingesting this stimulant during pregnancy, thus
suggesting that cocaine targets the developing brain. Cocaine
competitively inhibits the removal of synaptic dopamine (DA) and other
monoamines and thus increases synaptic concentrations of
neurotransmitters which are known to influence the development and
maturation of the CNS. It was therefore hypothesized that the increase
in synaptic transmitter concentrations during CNS maturation results in
cellular and neurochemical adaptive changes which lead to long term
behavioral aberrations. In previously performed investigations, we
demonstrated that prenatal exposure of rabbits to cocaine 1) reduced
coupline of D1 DA receptors to Galphas protein in cortex and striatum,
and 2) diminished evoked release of cortical DA. These effects were
observed on postnatal days 10 to 100. It is proposed that the
persistent functional changes in dopaminergic neurotransmission observed
after prenatal cocaine are the consequences of desensitization of the
D1 DA system that results from cocaine-induced insult to this
neurotransmitter system during gestation. The proposed studies aim at
defining the molecular mechanisms responsible for the apparent
uncoupling of the D1 DA receptor transduction system and the functional
consequences of this effect on DA neurotransmission. Specifically,
experiments are designed to 1) explore the role of posttranslational
modifications of Galphas and of D1 receptors in producing uncoupling of
the D1 receptor system, 2) establish how early in development D1
receptors uncouple from Gs, 3) test whether the D1 receptor also
uncouples from Galphaq which is linked to phosphatidylinositol
hydrolysis, 4) test whether D1 receptor-Gs uncoupling results in
desensitization of D1 receptor-mediated functions, and 5) test the
specificity of the effects of prenatal cocaine treatment in terms of
brain region, neurotransmitter system, and receptor subtype.
Understanding the mechanism by which in utero cocaine impairs normal
neurodevelopment and produces its long-term neurobehavioral
abnormalities will ultimately enable us to design specific strategies
to prevent or counter the consequences of cocaine abuse during
pregnancy.
皮质醇穿过胎盘并诱发神经行为异常
在母亲怀孕期间摄入这种兴奋剂的后代中,
表明可卡因的目标是发育中的大脑。 可卡因
竞争性抑制突触多巴胺(DA)和其他
单胺,从而增加突触浓度
已知影响发育的神经递质,
CNS的成熟。 因此,有人假设,
中枢神经系统成熟过程中突触递质浓度的变化,
细胞和神经化学的适应性变化,
行为失常 在以前的调查中,我们
表明兔子出生前接触可卡因1)减少了
D1 DA受体与皮质和纹状体中的Galphas蛋白偶联,
2)减少皮层DA的诱发释放。
在出生后10至100天观察。 拟议将
观察到多巴胺能神经传递的持续功能变化
产前可卡因后是脱敏的后果,
D1 DA系统,这是由于可卡因诱导的损伤,
妊娠期间的神经递质系统。 拟议的研究旨在
明确了导致
D1 DA受体转导系统的解偶联和功能性
这种影响对DA神经传递的后果。具体地说,
实验的目的是:1)探索翻译后的作用
修饰的Galphas和D1受体在产生解偶联的
D1受体系统,2)确定D1在发育的早期
受体与Gs解偶联,3)测试D1受体是否也
与连接到磷脂酰肌醇的Galphaq解偶联
水解,4)测试D1受体-Gs解偶联是否导致
D1受体介导的功能脱敏,和5)测试
产前可卡因治疗在以下方面影响的特异性:
脑区、神经递质系统和受体亚型。
了解子宫内可卡因损害正常
神经发育并产生其长期的神经行为
异常最终将使我们能够设计特定的策略,
预防或对付可卡因滥用的后果,
怀孕
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EITAN FRIEDMAN其他文献
EITAN FRIEDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EITAN FRIEDMAN', 18)}}的其他基金
DOPAMINE-LINKED PHOSPHOINOSITIDE METABOLISM IN BRAIN
脑中多巴胺连接的磷酸肌醇代谢
- 批准号:
2839337 - 财政年份:1998
- 资助金额:
$ 23.57万 - 项目类别:
PRENATAL COCAINE AND DOPAMINE RECEPTOR SIGNALING
产前可卡因和多巴胺受体信号传导
- 批准号:
6549360 - 财政年份:1998
- 资助金额:
$ 23.57万 - 项目类别:
相似国自然基金
抗可卡因(Cocaine)抗体酶的研制及实验研究
- 批准号:39570633
- 批准年份:1995
- 资助金额:8.5 万元
- 项目类别:面上项目
相似海外基金
Investigate Host Gene Isoforms Contributing to HIV Persistence in Cocaine Users
研究导致可卡因吸食者中艾滋病毒持续存在的宿主基因亚型
- 批准号:
10788990 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
The role of nucleus accumbens dopamine in incubation of cocaine craving
伏隔核多巴胺在可卡因渴望孵化中的作用
- 批准号:
10676025 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
Repurposing Metformin as a Treatment for Cocaine Use Disorder
重新利用二甲双胍治疗可卡因使用障碍
- 批准号:
10823844 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
Modeling cue-triggered relapse to cocaine use in rats
模拟提示触发大鼠可卡因吸毒复发
- 批准号:
479766 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
Operating Grants
Hippocampal mechanisms of cocaine-memory reconsolidation
可卡因记忆重建的海马机制
- 批准号:
10736775 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
Nucleus accumbens cholinergic interneurons and cue-induced cocaine craving
伏核胆碱能中间神经元和提示诱导的可卡因渴望
- 批准号:
10738973 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
TASK ORDER 01 COCAINE INTERACTION SAFETY STUDIES IN RATS. TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS IDIQ. ORDERING PERIOD: 09/12/2023 - 09/11/2024. NIDA REF. NO. N01DA-23-8939
任务单 01 可卡因相互作用在大鼠中的安全性研究。
- 批准号:
10947939 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
Endocannabinoid regulation of the corticoaccumbens pathway and stress-enhanced cocaine-seeking behavior
内源性大麻素对伏隔皮质通路的调节和压力增强的可卡因寻求行为
- 批准号:
10750394 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
Targeting Phospholipase C and Dendritic Spines to Reduce Cocaine and Heroin Motivation
靶向磷脂酶 C 和树突棘以减少可卡因和海洛因动机
- 批准号:
10929771 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别:
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
使用 Cav3 通道和可溶性环氧化物水解酶的 IND 双重抑制剂开发可卡因使用障碍的新型治疗方法
- 批准号:
10786151 - 财政年份:2023
- 资助金额:
$ 23.57万 - 项目类别: